|
gptkb:HLX03_(adalimumab_biosimilar)
|
ankylosing spondylitis
|
|
gptkb:Atenolol_Accord
|
hypertension
|
|
gptkb:Neupogen
|
peripheral blood progenitor cell collection
|
|
gptkb:sintilimab
|
gptkb:non-small_cell_lung_cancer
|
|
gptkb:CHEMBL191
|
gptkb:arrhythmia
|
|
gptkb:Gablofen
|
severe spasticity of cerebral or spinal origin
|
|
gptkb:tepotinib
|
MET exon 14 skipping mutation-positive NSCLC
|
|
gptkb:CHEMBL502
|
hypertension
|
|
gptkb:CHEMBL472
|
gptkb:KIT-positive_gastrointestinal_stromal_tumors
|
|
gptkb:SDG_9:_Industry,_Innovation_and_Infrastructure
|
Proportion of the rural population who live within 2 km of an all-season road
|
|
gptkb:tafenoquine
|
malaria prophylaxis
|
|
gptkb:Bleeding_Eyes
|
Eye injury
|
|
gptkb:Zosyn
|
skin and soft tissue infection
|
|
gptkb:Ultra_Rare_rarity
|
very low probability of obtaining item
|
|
gptkb:C-clef
|
position of middle C
|
|
gptkb:Imfinzi
|
gptkb:extensive-stage_small_cell_lung_cancer
|
|
gptkb:CHEMBL1093
|
gptkb:arrhythmia
|
|
gptkb:SDG_12:_Responsible_Consumption_and_Production
|
12.8.1 Extent to which education for sustainable development is mainstreamed
|
|
gptkb:Parmigiano_Reggiano_mark
|
PDO status
|
|
gptkb:UL_mark
|
product has been tested
|